MedWatch

Novo Holdings and Healthcap launch new biotech firm

Novo Holdings is playing a crucial role in the establishment of the new biotech firm Tribune Therapeutics which will exploit a new pan-antifibrotic mechanism across a wide range of indications.

Photo: Novo Holdings / PR

Holdings company Novo Nordisk has established a new biotech firm, Tribune Therapeutics, according to a company press release.

The new firm will use a new pan-antifibrotic mechanism across a wide range of indications.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs